EV/EBITDA
-3.79
+1.83+32.56%
Fri, 21 Feb 2025 21:05:01 GMT
Summary
- As of February 22, 2025, BCAX EV/EBITDA is -3.79, with a rise of +1.83 (+32.56%) during the most recent trading day.
- BCAX EV/EBITDA is now -474.24% below its all-time high of -0.66.
Performance
BCAX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
BCAX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +32.6% | -32.6% | -5.9% |
| 1 m1 month | -474.2% | +474.2% | +12.1% |
| 3 m3 months | +73.8% | -73.8% | -26.8% |
| 6 m6 months | - | - | - |
| ytdytd | +72.2% | -72.3% | -25.4% |
| 1 y1 year | - | - | - |
| 5 y5 years | - | - | - |
BCAX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -474.2% | -5.62 | +32.6% | |
| 3 m | 3-month | -0.66 | -474.2% | -21.96 | +82.7% |
| 6 m | 6-month | -0.66 | -474.2% | -31.63 | +88.0% |
| 1 y | 1-year | -0.66 | -474.2% | -31.63 | +88.0% |
| 3 y | 3-year | -0.66 | -474.2% | -31.63 | +88.0% |
| 5 y | 5-year | -0.66 | -474.2% | -31.63 | +88.0% |
| alltime | all time | -0.66 | -474.2% | -31.63 | +88.0% |
Bicara Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.79(-72.2%) |
| Date | Value |
|---|---|
| 2024 | -13.65 |
FAQ
- What is Bicara Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Bicara Therapeutics?
- What is BCAX EV/EBITDA year-to-date change?
What is Bicara Therapeutics EV/EBITDA?
The current EV/EBITDA of BCAX is -3.79
What is the all time high EV/EBITDA for Bicara Therapeutics?
Bicara Therapeutics all-time high EV/EBITDA is -0.66
What is BCAX EV/EBITDA year-to-date change?
Bicara Therapeutics EV/EBITDA has changed by +9.86 (+72.23%) since the beginning of the year